title: Management of steroid-resistant late acute cellular rejection following face transplantation: a case report.
abstract: Face transplants have been clinically established, and early acute rejections have been reported. Late acute rejections have been less common. Immediate and accurate diagnosis along with successful treatment is critical to prevent graft damage. This case report describes the successful treatment of a severe, steroid-resistant rejection 2 years after a full face transplant.
authors: Department of Plastic Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Jeffrey.Janis@osumc.edu.
authors: J E
authors: JE
authors: Janis
authors: Department of Transplant, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: K D
authors: KD
authors: MacKenzie
authors: Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: S E
authors: SE
authors: Wright
authors: Department of Plastic Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
authors: B
authors: B
authors: Pomahac
authors: Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: C
authors: C
authors: Lu
authors: Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: J
authors: J
authors: Susa
authors: Department of Infectious Disease, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: S
authors: S
authors: Wada
authors: Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: M A
authors: MA
authors: Vazquez
authors: Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
authors: T
authors: T
authors: Chong
authors: Division of Transplant Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
authors: S G
authors: SG
authors: Tullius
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002056:Burns / Q000601:surgery*; D005151:Facial Injuries / Q000601:surgery*; D054445:Facial Transplantation / Q000009:adverse effects*; D006084:Graft Rejection / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; C512542:thymoglobulin